Detecting drug-induced nephrotoxicity using simultaneous label-free autofluorescence multiharmonic microscopy
Open Access
- 18 August 2026
- journal article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (9)
Abstract
Drug-induced nephrotoxicity (DIN) is a major cause of drug development failure, yet many cases are detected only late in clinical trials or after approval. Conventional methods to detect DIN often lack sensitivity and specificity, particularly for early or region-specific kidney injury. Here, we evaluate Simultaneous Label-free Autofluorescence Multiharmonic (SLAM) microscopy as a rapid, label-free imaging approach to quantify kidney microstructural and functional metabolic changes associated with DIN. SLAM simultaneously captures endogenous NAD(P)H and FAD autofluorescence, collagen-derived second harmonic generation, and third-harmonic generation from structural interfaces. SLAM images were acquired from the cortex and outer medulla (OM) of rat kidneys after cisplatin dosing at days 1, 6, and 29 post-administration. Imaging revealed region-specific injury, with the OM showing greater sensitivity to DIN than the cortex. The most prominent changes—tubular degeneration and hyaline casts—peaked at day 6, whereas tubular dilation and fibrosis-related features persisted to day 29. Feature-based classification captured these spatial and temporal patterns, achieving higher balanced accuracy in the OM (0.944) than in the cortex (0.860). Key model drivers included granularity and inter-channel correlations, underscoring the value of multi-channel SLAM data. Overall, these results demonstrate the potential of SLAM microscopy for sensitive, region-specific detection and characterization of DIN in preclinical safety studies. SLAM microscopy provides a rapid, label-free way to detect, localize, and classify drug-induced nephrotoxicity with improved sensitivity and regional specificity, potentially strengthening preclinical kidney safety screening and reducing late-stage development failures.Keywords
Funding Information
- NIH/NIBIB Center for Label-free Imaging in Multiscale Biophotonics (P41EB031772)
This publication has 36 references indexed in Scilit:
- From animal models to new approach methodologies: Opportunities and challengesThe Innovation, 2026
- Spatio-temporal transcriptomic analysis reveals distinct nephrotoxicity, DNA damage, and regeneration response after cisplatinCell Biology and Toxicology, 2025
- Towards Non-Animal Testing in European Regulatory Toxicology: An Introduction to the REACH Framework and Challenges in Implementing the 3RsEuropean Journal of Risk Regulation, 2025
- Predicting DNA damage response in non-small cell lung cancer organoids via simultaneous label-free autofluorescence multiharmonic microscopyRedox Biology, 2024
- Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic ApproachTherapeutic Innovation & Regulatory Science, 2023
- Slide OverThe American Journal of Pathology, 2022
- Relationship between intracellular pH, metabolic co-factors and caspase-3 activation in cancer cells during apoptosisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2017
- Label‐free in vivo cellular‐level detection and imaging of apoptosisJournal of Biophotonics, 2016
- Cisplatin in cancer therapy: Molecular mechanisms of actionEuropean Journal of Pharmacology, 2014
- Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals.Journal of Biological Chemistry, 1979